Literature DB >> 34073892

The Roles of Various Prostaglandins in Fibrosis: A Review.

Ke Li1, Jing Zhao1, Mingxuan Wang1, Lingzhi Niu1, Yuanping Wang1, Yanxia Li1, Yajuan Zheng1.   

Abstract

Organ fibrosis is a common pathological result of various chronic diseases with multiple causes. Fibrosis is characterized by the excessive deposition of extracellular matrix and eventually leads to the destruction of the tissue structure and impaired organ function. Prostaglandins are produced by arachidonic acid through cyclooxygenases and various prostaglandin-specific synthases. Prostaglandins bind to homologous receptors on adjacent tissue cells in an autocrine or paracrine manner and participate in the regulation of a series of physiological or pathological processes, including fibrosis. This review summarizes the properties, synthesis, and degradation of various prostaglandins, as well as the roles of these prostaglandins and their receptors in fibrosis in multiple models to reveal the clinical significance of prostaglandins and their receptors in the treatment of fibrosis.

Entities:  

Keywords:  PGD2; PGE2; PGF2α; PGI2; TXA2; fibrosis; myofibroblast

Year:  2021        PMID: 34073892     DOI: 10.3390/biom11060789

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  103 in total

Review 1.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

Review 2.  Modulation of Fibroblasts in Conjunctival Wound Healing.

Authors:  Mark Zada; Ushasree Pattamatta; Andrew White
Journal:  Ophthalmology       Date:  2017-11-01       Impact factor: 12.079

3.  Effect of 15-hydroxyprostaglandin dehydrogenase inhibitor on wound healing.

Authors:  Seung Yong Seo; Song-Iy Han; Chun Sik Bae; Hoon Cho; Sung Chul Lim
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-04-07       Impact factor: 4.006

Review 4.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

5.  FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis.

Authors:  Loka R Penke; Jennifer M Speth; Vijaya L Dommeti; Eric S White; Ingrid L Bergin; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

6.  Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling.

Authors:  Katsuhide Okunishi; Thomas H Sisson; Steven K Huang; Cory M Hogaboam; Richard H Simon; Marc Peters-Golden
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

7.  Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

Authors:  J Wilborn; L J Crofford; M D Burdick; S L Kunkel; R M Strieter; M Peters-Golden
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways.

Authors:  Steven K Huang; Eric S White; Scott H Wettlaufer; Heather Grifka; Cory M Hogaboam; Victor J Thannickal; Jeffrey C Horowitz; Marc Peters-Golden
Journal:  FASEB J       Date:  2009-08-11       Impact factor: 5.191

9.  PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-λ production.

Authors:  Rhiannon B Werder; Jason P Lynch; Jennifer C Simpson; Vivian Zhang; Nick H Hodge; Matthew Poh; Elizabeth Forbes-Blom; Christina Kulis; Mark L Smythe; John W Upham; Kirsten Spann; Mark L Everard; Simon Phipps
Journal:  Sci Transl Med       Date:  2018-05-09       Impact factor: 17.956

10.  Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis.

Authors:  Taiki Kida; Shinya Ayabe; Keisuke Omori; Tatsuro Nakamura; Toko Maehara; Kosuke Aritake; Yoshihiro Urade; Takahisa Murata
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

View more
  3 in total

Review 1.  The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis.

Authors:  Carol M Artlett
Journal:  Biomolecules       Date:  2022-04-26

2.  Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies.

Authors:  Hugo Garcia; Alice S Serafin; Flora Silbermann; Esther Porée; Amandine Viau; Clémentine Mahaut; Katy Billot; Éléonore Birgy; Meriem Garfa-Traore; Stéphanie Roy; Salomé Ceccarelli; Manon Mehraz; Pamela C Rodriguez; Bérangère Deleglise; Laetitia Furio; Fabienne Jabot-Hanin; Nicolas Cagnard; Elaine Del Nery; Marc Fila; Soraya Sin-Monnot; Corinne Antignac; Stanislas Lyonnet; Pauline Krug; Rémi Salomon; Jean-Philippe Annereau; Alexandre Benmerah; Marion Delous; Luis Briseño-Roa; Sophie Saunier
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-28       Impact factor: 12.779

3.  A novel prostaglandin I2 agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice.

Authors:  Satoko Motegi; Atsunori Tsuchiya; Takahiro Iwasawa; Takeki Sato; Masaru Kumagai; Kazuki Natsui; Shunsuke Nojiri; Masahiro Ogawa; Suguru Takeuchi; Yosiki Sakai; Shigeru Miyagawa; Yoshiki Sawa; Shuji Terai
Journal:  Inflamm Regen       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.